Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer Image: iStock/SciePro Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer Patients with stage 4 lung cancer show high response rates after an anti-inflammatory drug is added temporarily to immune checkpoint inhibitor therapy.
New immunotherapy combination could ‘change the landscape’ of cancer treatment Penn In the News Stat New immunotherapy combination could ‘change the landscape’ of cancer treatment A study by Andy Minn and postdoc Divij Mathew of the Perelman School of Medicine and colleagues found that a combination checkpoint inhibitor therapy benefited patients with lung cancer. Kotaro Sasaki and his team unveil the genetics of testicular cancer Section of seminoma tissue, a type of testicular cancer, showing strong expression of proteins/RNAs (TFAP2C, green; BICD1, red) that are typically present in pre-migratory/migratory primordial germ cells, precursors of sperm.(Image: Courtesy of Kotaro Sasaki) Kotaro Sasaki and his team unveil the genetics of testicular cancer Researchers from Penn Vet develop the first in vitro seminoma model, shedding light on chromosomal anomalies and signaling pathways. Breast cancer strikes young Black women at alarming rate Penn In the News Philadelphia Inquirer Breast cancer strikes young Black women at alarming rate Oluwadamilola “Lola” Fayanju of the Perelman School of Medicine analyzes the factors causing breast cancer to affect younger women. New ‘armored’ CAR therapy produces significant responses in cancer patients Image: iStock/tiratus phaesuwan New ‘armored’ CAR therapy produces significant responses in cancer patients For patients whose cancers don't respond to current CAR T cell therapies, a new, modified CAR T cell therapy by Penn’s Carl June shows promise in a phase 1 clinical trial. Could the liver hold the key to better cancer treatments? Image: iStock/Md Babul Hosen Could the liver hold the key to better cancer treatments? Penn Medicine researchers have uncovered a liver-based signaling pathway that protects tumors by restraining anticancer immune cells. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that Penn In the News CNN There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Load More
Kotaro Sasaki and his team unveil the genetics of testicular cancer Section of seminoma tissue, a type of testicular cancer, showing strong expression of proteins/RNAs (TFAP2C, green; BICD1, red) that are typically present in pre-migratory/migratory primordial germ cells, precursors of sperm.(Image: Courtesy of Kotaro Sasaki) Kotaro Sasaki and his team unveil the genetics of testicular cancer Researchers from Penn Vet develop the first in vitro seminoma model, shedding light on chromosomal anomalies and signaling pathways.
Breast cancer strikes young Black women at alarming rate Penn In the News Philadelphia Inquirer Breast cancer strikes young Black women at alarming rate Oluwadamilola “Lola” Fayanju of the Perelman School of Medicine analyzes the factors causing breast cancer to affect younger women. New ‘armored’ CAR therapy produces significant responses in cancer patients Image: iStock/tiratus phaesuwan New ‘armored’ CAR therapy produces significant responses in cancer patients For patients whose cancers don't respond to current CAR T cell therapies, a new, modified CAR T cell therapy by Penn’s Carl June shows promise in a phase 1 clinical trial. Could the liver hold the key to better cancer treatments? Image: iStock/Md Babul Hosen Could the liver hold the key to better cancer treatments? Penn Medicine researchers have uncovered a liver-based signaling pathway that protects tumors by restraining anticancer immune cells. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that Penn In the News CNN There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Load More
New ‘armored’ CAR therapy produces significant responses in cancer patients Image: iStock/tiratus phaesuwan New ‘armored’ CAR therapy produces significant responses in cancer patients For patients whose cancers don't respond to current CAR T cell therapies, a new, modified CAR T cell therapy by Penn’s Carl June shows promise in a phase 1 clinical trial.
Could the liver hold the key to better cancer treatments? Image: iStock/Md Babul Hosen Could the liver hold the key to better cancer treatments? Penn Medicine researchers have uncovered a liver-based signaling pathway that protects tumors by restraining anticancer immune cells.
Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn.
Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy.
There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that Penn In the News CNN There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles.
Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles.